No abstract available
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Antibodies, Monoclonal / therapeutic use
-
Benzamides
-
Drug Resistance, Neoplasm / genetics
-
Gene Expression Regulation, Neoplastic
-
Hematologic Neoplasms / drug therapy
-
Humans
-
Imatinib Mesylate
-
Mutation
-
Neoplasms / drug therapy*
-
Neoplasms / enzymology
-
Piperazines / therapeutic use
-
Protein Kinase Inhibitors / therapeutic use*
-
Protein-Tyrosine Kinases / antagonists & inhibitors*
-
Protein-Tyrosine Kinases / metabolism
-
Proto-Oncogene Proteins / antagonists & inhibitors
-
Pyrimidines / therapeutic use
-
Receptor Protein-Tyrosine Kinases / antagonists & inhibitors*
-
Receptor Protein-Tyrosine Kinases / genetics
-
fms-Like Tyrosine Kinase 3
Substances
-
Antibodies, Monoclonal
-
Benzamides
-
Piperazines
-
Protein Kinase Inhibitors
-
Proto-Oncogene Proteins
-
Pyrimidines
-
Imatinib Mesylate
-
FLT3 protein, human
-
Protein-Tyrosine Kinases
-
Receptor Protein-Tyrosine Kinases
-
fms-Like Tyrosine Kinase 3